Amgen’s Aranesp

Make a comment

By Ed Silverman // April 19th, 2007 // 11:32 am

Falls Short
In Study
(Yahoo/AP)Amgen’s Aranesp

Jump to comments

Share

Comments are closed.

Subscribe

RSS Feed

Comments feed for this post only.

Tags

« Enbrel Royalties: From The Lab To The Bank
Quest Diagnostics »

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/